13 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

CODIAGNOSTIX (R) 5.72

FDA 510(k)
FDA Class 2 ·Radiology

KMEDIC

FDA UDI
TELEFLEX INCORPORATED·24026704293739·

NA

FDA UDI
KEY SURGICAL, INC.·10849771049897·Steinmann Pins, Single diamond, 3 shank end, 7/...

C-REACTIVE PROTEIN ANTISERUM KIT

FDA 510(k)
FDA Class 2 ·Immunology

ALBUMIN REAGENT

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

SPECTRA WAVEWRITER?

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC NEUROMODULATION CORPORATION·Product code LGW·March 17, 2026

ADAPTA

FDA Adverse Event
Malfunction ·MEDTRONIC MED REL MEDTRONIC PUERTO RICO·Product code NVZ·April 22, 2013

UNKNOWN DEPUY ASR SZ. 57 HEAD

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL, LTD.·Product code KWA·April 15, 2011

PULSE GEN MODEL 102

FDA Adverse Event
Injury ·CYBERONICS, INC.·Product code LYJ·July 9, 2008

Equinoxe Reverse Shoulder Compression Screw/Locking Cap Kit 4.5 x 22 mm.

FDA Enforcement
Class II ·Terminated·Exactech, Inc.·October 7, 2020

The PRM is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all communication functions for the pulse generator.

FDA Enforcement
Class II ·Ongoing·Boston Scientific Corporation·September 7, 2022

The Programmer/Recorder/Monitor (PRM) is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all communication functions for the pulse generator.

FDA Enforcement
Class II ·Ongoing·Boston Scientific Corporation·September 7, 2022

The PRM is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all communication functions for the pulse generator.

FDA Enforcement
Class II ·Ongoing·Boston Scientific Corporation·September 7, 2022